Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Cost Effectiveness of Standard Versus Pharmacokinetic Dosing During Factor VIII Prophylaxis in Adult Patients With Severe Haemophilia A

NCT02697370 is registered in ClinicalTrials.gov with Hampshire Hospitals NHS Foundation Trust as lead sponsor.

NCT NCT02697370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02697370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Cost Effectiveness of Standard Versus Pharmacokinetic Dosing During Factor VIII Prophylaxis in Adult Patients With Severe Haemophilia A
Lead sponsor
Hampshire Hospitals NHS Foundation Trust
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2013
Completion date
May 31, 2015
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe haemophilia a